EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gold Nanoparticles in Central Nervous System Diseases: Recent Progress, Challenges, and Therapeutic Opportunities

Shunping Han, Salima Bouchrara iD, Khuloud T Al-Jamal iD

Nano Letters · 10.06.2026 · 26 (22) · 7184-7192

DOI: 10.1021/acs.nanolett.6c00540 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nano Letters, online erschienen am 27.05.2026. Verfasst von Shunping Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, Franklin-Wilkins Building, 150 Stamford Street, Lond…. Hauptthemen laut MEDLINE: Gold, Metal Nanoparticles, Central Nervous System Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Brain Tumour Charity, University of Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Central nervous system (CNS) diseases, including neurodegenerative disorders and brain cancers, remain leading causes of disability and death, largely due to limited drug penetration across the blood-brain barrier (BBB). Gold nanoparticles (AuNPs) have emerged as versatile platforms for CNS applications, with tunable morphology, surface chemistry, and optical properties, enabling both therapeutic and diagnostic use. This review highlights recent advances in the design and optimization of AuNPs for brain-targeted delivery, explores their applications in CNS diseases, and discusses current challenges, safety considerations, and future prospects for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldMetal NanoparticlesCentral Nervous System DiseasesHumansBlood-Brain BarrierAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

Brain deliveryCentral nervous system diseasesGold nanoparticlesTherapeutic applicationToxicity

Substanzen

Gold

Autor:innen und Institutionen

  • Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom.
  • Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam 999077, Hong Kong, China.

ORCID-Profile: Salima Bouchrara, Khuloud T Al-Jamal

Förderung

  • Wellcome Trust
  • Brain Tumour Charity
  • University of Hong Kong
  • Brain Research UK
  • China Scholarship Council
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Han, S., Bouchrara, S., & Al-Jamal, K. T. (2026). Gold Nanoparticles in Central Nervous System Diseases: Recent Progress, Challenges, and Therapeutic Opportunities. Nano Letters, 26(22), 7184-7192. https://doi.org/10.1021/acs.nanolett.6c00540

Vancouver

Han S, Bouchrara S, Al-Jamal KT. Gold Nanoparticles in Central Nervous System Diseases: Recent Progress, Challenges, and Therapeutic Opportunities. Nano Letters. 2026;26(22):7184-7192. doi:10.1021/acs.nanolett.6c00540

BibTeX
@article{Han2026,
  author = {Han, Shunping and Bouchrara, Salima and Al-Jamal, Khuloud T},
  title = {Gold Nanoparticles in Central Nervous System Diseases: Recent Progress, Challenges, and Therapeutic Opportunities},
  journal = {Nano Letters},
  year = {2026},
  volume = {26},
  number = {22},
  pages = {7184--7192},
  doi = {10.1021/acs.nanolett.6c00540}
}
Kostenlos starten →